4.3 Article Proceedings Paper

Sodium Intake and Blood Pressure in Patients with Chronic Kidney Disease: A Salty Relationship

期刊

BLOOD PURIFICATION
卷 45, 期 1-3, 页码 166-172

出版社

KARGER
DOI: 10.1159/000485154

关键词

Chronic kidney disease; Sodium intake; Salt intake; Blood pressure

资金

  1. Janssen
  2. AstraZeneca
  3. Novartis
  4. Akebia
  5. Baxter
  6. Fresenius Medical Care

向作者/读者索取更多资源

Background: Hypertension affects almost all chronic kidney disease patients and is related to poor outcomes. Sodium intake is closely related to blood pressure (BP) levels in this population and decreasing its intake consistently improves the BP control particularly in short-term controlled trials. However, most patients struggle in following a controlled diet on sodium according to the guidelines recommendation due to several factors and barriers discussed in this article. Summary: This review article summarizes the current knowledge related to the associations between sodium consumption, BP, and the risk of cardiovascular disease and chronic kidney disease (CKD); it also provides recommendations of how to achieve sodium intake lowering. Key Messages: Evidences support the benefits in decreasing sodium intake on markers of cardiovascular and renal outcomes in CKD. Trials had shorter follow-up and to maintain long-term sodium intake control is a major challenge. Larger studies with longer follow-up looking at hard endpoints will be important to drive future recommendations. (c) 2018 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据